Live Breaking News & Updates on Disc Medicine Opco Inc Stock Exchange

Stay updated with breaking news from Disc medicine opco inc stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Disc Medicine Opco : Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress - Form 8-K

Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic. | June 9, 2023 ....

Christina Tartaglia , John Quisel , Verge Scientific Communications , Exchange Commission , European Hematology Association , Disc Medicine Inc , Disc Presents Positive Initial Data , Erythropoietic Protoporphyria , Chief Executive Officer , Will Savage , Chief Medical Officer , Global Impression , X Linked Protoporphyria , Private Securities Litigation Reform Act , Quarterly Report , Disc Medicine Opco Inc Stock Exchange , Press Release , Erious Iron Us2546041011 ,

Disc Medicine Opco : Reports First Quarter 2023 Financial Results and Provides Business Update - Form 8-K

Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic. | May 15, 2023 ....

Suzanne Messere , John Quisel , Exchange Commission , Verge Scientific Communications , Congress On , European Hematology Association , Bain Capital Life Sciences , Disc Medicine Inc , Development Expenses , Disc Medicine Reports First Quarter , Provides Business , Mabwell Therapeutics , Bain Capital Life , Chief Executive Officer , Business Highlights , Upcoming Milestones , Heme Synthesis Modulator , Orphan Designation , European Committee , Orphan Medical Products , Drug Designation , Diamond Blackfan Anemia , Anti Hemojuvelin Antibody , Hepcidin Suppression , Hepcidin Induction , Transmembrane Serine Protease ,

Disc Medicine Opco : Erythropoietic Protoporphyria (EPP) and Bitopertin Presentation

Erythropoietic Protoporphyria and Bitopertin

April 25, 2023

Disclaimer and FLS

This presentation includes. | April 25, 2023 ....

Exchange Commission , Private Securities Litigation Reform Act , Annual Report , Disc Medicine Opco Inc Stock Exchange , Press Release , Resentation Iron Us2546041011 ,

Disc Medicine Opco : Reports Full Year 2022 Financial Results and Provides Business Update - Form 8-K

Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic. | March 31, 2023 ....

United States , Suzanne Messere , Arix Bioscience , John Quisel , European Committee For Orphan Medical Products , Novo Holdings , European Hematology Association Annual Congress , Atlas Venture , Disc Medicine Inc , Development Expenses , Verge Scientific Communications , Bain Capital Life Sciences , Drug Administration , American Society Of Hematology Annual Meeting , Exchange Commission , Disc Medicine Reports Full Year , Provides Business , Gemini Therapeutics , Chief Executive Officer , Anticipated Milestones , Heme Synthesis Modulator , Orphan Drug Designation , European Committee , Orphan Medical Products , Orphan Designation , Diamond Blackfan Anemia ,